After new Covid strains, govt issues fresh guidelines

The government has issued a fresh set of travel guidelines as two new, highly more infectious strains of Covid – the South African and the Brazilian strains – have been detected in India. Continue Reading

Neuberg gets nod for Covid tests in four more cities

Neuberg Diagnostics has received approval from the Indian Council of Medical Research (ICMR) for conducting Covid-19 tests in Noida , UP (Delhi NCR), Visakhapatnam, Andhra Pradesh; Salem, Tamilnadu and Kozhikode, Kerala. Continue Reading

All eyes on India’s anti-Covid drive

The Central Drugs and Standards Committee (CDSCO) on Sunday formally approved the Covid-19 vaccines by Bharat Biotech and the Serum Institute of India (SII). Continue Reading

Expert panel okays Covishield, puts Covaxin on hold

In a huge step towards controlling the spread of the Coronavirus, India on Friday saw an expert panel clearing the Oxford Covid-19 vaccine, manufactured by the Serum Institute of India, even as a dry run of the inoculation programme is to be carried out in the country today. Continue Reading

Editorial: Tough times

After the notification of the new, mutated variant of the coronavirus has come to the fore, there is palpable anxiety with people wondering if the new strain has reached India. Continue Reading

Ocugen, Bharat Biotech to co-develop Covaxin for US

Drug developer Ocugen Inc said on Tuesday it had partnered with Bharat Biotech to co-develop the Hyderabad-based company’s Covid-19 vaccine candidate for the US market. Continue Reading

‘Vaccinating 130 cr people with injectable Covaxin a challenge’

Even as India’s first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on how to vaccinate 1.3 billion (130 crore) people with two injectable doses. Terming the exercise a challenge it also said that work was on single-dose nasal drop vaccine. Continue Reading

Covaxin: Bharat Biotech gets nod for phase 3 trials

Covaxin, the Coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials. Continue Reading